TruScreen Group Limited (NZE: TRU)
New Zealand
· Delayed Price · Currency is NZD 0.0240
0.00 (0.00%)
Jan 3, 2025, 4:42 PM NZST
TruScreen Group Company Description
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.
The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time.
The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020.
TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
TruScreen Group Limited
| Country | New Zealand |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Martin Dillon |
Contact Details
Address: Equitable House Auckland, 1010 New Zealand | |
| Phone | 61 2 8999 3896 |
| Website | truscreen.com |
Stock Details
| Ticker Symbol | TRU |
| Exchange | New Zealand Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZTRUE0001S7 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Martin Dillon | Chief Executive Officer |
| Guy Robertson | Chief Financial Officer |